AbbVie (ABBV)
(Delayed Data from NYSE)
$185.16 USD
+2.99 (1.64%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $185.99 +0.83 (0.45%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/25/24 |
---|---|
Current Quarter | 2.91 |
EPS Last Quarter | 2.65 |
Last EPS Surprise | 3.11% |
ABR | 1.67 |
Earnings ESP
|
0.38% |
---|---|
Current Year | 10.86 |
Next Year | 12.07 |
EPS (TTM) | 10.70 |
P/E (F1) | 17.06 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.15B | 14.83B | 55.33B | 58.79B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 14.37B | 15.26B | 56.03B | 60.19B |
Low Estimate | 13.94B | 14.60B | 54.79B | 57.18B |
Year ago Sales | 13.93B | 14.30B | 54.32B | 55.33B |
Year over Year Growth Est. | 1.57% | 3.68% | 1.86% | 6.25% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.91 | 3.00 | 10.86 | 12.07 |
# of Estimates | 10 | 9 | 12 | 12 |
Most Recent Consensus | 2.85 | 3.01 | 10.76 | 11.96 |
High Estimate | 3.02 | 3.08 | 11.25 | 12.63 |
Low Estimate | 2.84 | 2.92 | 10.61 | 11.55 |
Year ago EPS | 2.95 | 2.79 | 11.11 | 10.86 |
Year over Year Growth Est. | -1.36% | 7.53% | -2.25% | 11.18% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 1 | 0 | 3 |
Up Last 30 Days | 2 | 1 | 0 | 3 |
Up Last 60 Days | 3 | 2 | 0 | 4 |
Down Last 7 Days | 2 | 6 | 2 | 5 |
Down Last 30 Days | 5 | 8 | 10 | 7 |
Down Last 60 Days | 4 | 7 | 10 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.91 | 3.00 | 10.86 | 12.07 |
7 Days Ago | 2.90 | 3.02 | 10.93 | 12.13 |
30 Days Ago | 2.89 | 3.03 | 11.27 | 12.10 |
60 Days Ago | 2.88 | 3.03 | 11.26 | 12.08 |
90 Days Ago | 2.91 | 3.12 | 11.16 | 12.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.93 | 3.00 | 10.78 | 12.06 |
Zacks Consensus Estimate | 2.91 | 3.00 | 10.86 | 12.07 |
Earnings ESP | 0.38% | 0.00% | -0.71% | -0.10% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.65 | 2.31 | 2.79 | 2.95 | NA |
Estimate | 2.57 | 2.26 | 2.76 | 2.86 | NA |
Difference | 0.08 | 0.05 | 0.03 | 0.09 | 0.06 |
Surprise | 3.11% | 2.21% | 1.09% | 3.15% | 2.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more